PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising breakthroughs across various health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, more dependable alternative for therapeutic us